Novocell Hires CEO

Irvine-based Novocell has hired a new CEO, saying today that it has appointed Alan Lewis as President and CEO of the firm. Novocell is looking to commercialize stem cell therapies and drugs for diabetes and other chronic diseases. Lewis has served at Signal Pharmaceuticals, Wyeth-Ayerst, and other companies. He also is a director of Discovery Partners International. More information »